Back to BlackRock, Inc. BlackRock, Inc.

ABCLABCL
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ABCELLERA BIOLOGICS INC

BlackRock, Inc. holds 3.8M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $29.9M as of 2026-Q2. The position was decreased (-5.8% shares). ABCL represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$29.9M

Current Shares

3.8M

Total Value Change

+$17.9M

Total Shares Change

-291,334

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.8M
-5.8%
$29.9M0.0%$7.85
0
2026-Q1
Increased
4M
+4.5%
$14.1M0.0%$3.71
29
2025-Q4
Increased
3.9M
+6.2%
$13.2M0.0%$3.45
30
2025-Q3
Decreased
3.6M
-1.1%
$18.3M0.0%$4.87
0
2025-Q2
Increased
3.7M
+2.9%
$12.6M0.0%$3.61
29
2025-Q1
Decreased
3.6M
-12.7%
$8M0.0%$2.31
0
2024-Q4
New
4.1M
-
$12M0.0%$2.82
39

Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used